about
Sex Steroid Hormone Single-Nucleotide Polymorphisms, Pesticide Use, and the Risk of Prostate Cancer: A Nested Case-Control Study within the Agricultural Health StudyLong-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.Decisional outcomes following use of an interactive web-based decision aid for prostate cancer screeningLong-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillanceConsumption of caffeinated and artificially sweetened soft drinks is associated with risk of early menarche.Through the lens of culture: quality of life among Latina breast cancer survivors.Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trialAdiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort.Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.Men's use of an Internet-based decision aid for prostate cancer screening.Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management.Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors.Monitoring of health-related quality of life and symptoms in prostate cancer survivors: a randomized trial.Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.Breast cancer in Portugal: Temporal trends and age-specific incidence by geographic regions.Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.Framework to construct and interpret latent class trajectory modellingBody mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health StudyUsual adult occupation and risk of prostate cancer in West African men: the Ghana Prostate StudyAssociation of Leisure-Time Physical Activity Across the Adult Life Course With All-Cause and Cause-Specific MortalityChanging Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United StatesEndophthalmitis after Cataract Surgery in the United States: A Report from the Intelligent Research in Sight Registry, 2013-2017A population-based study of cardiovascular disease mortality risk in US cancer patientsReturn to the Operating Room for Removal of Retained Lens Fragments after Cataract Surgery: IRIS® Registry (Intelligent Research in Sight) Analysis
P50
Q28394503-6E1084C3-0D3D-4739-A206-F09AD6EBBD8AQ34197475-14D502F2-10CA-4DCD-9FBE-29B5ACA5F1DFQ34527229-4579A0A3-487B-46F5-8C7C-DEDB310BF6D3Q35192381-5B153EFA-4D87-4138-A1E1-CC153C7F3EA7Q35650094-EB435164-5321-43BD-ABC0-9D4700821418Q35777905-A6EF6879-999A-4CAE-829A-6A34A0D57EE2Q35992572-3B630D24-2300-4D62-9313-9F524034AA4BQ36540565-86B046F8-B14D-48E8-9295-7553D5845EBBQ36792125-F22FE491-5A70-40A0-905D-C450590A36E7Q37137944-74815AF0-E2B7-4D5B-BD9C-CFF9898E4100Q37711882-57A4AF26-FF5F-4476-AF03-96F858B22C46Q38730180-CCC43A2A-CD53-45AD-BA2E-994753599EACQ38752784-1D4DCA7F-2E24-4A75-9F2F-4EE36E8E3F95Q38962148-81BA68E5-8786-4416-B83C-4D5AC0C40C7BQ39927173-E63AAF1D-3DF6-4F5B-A82F-185482FA18BDQ39998901-56A5A814-4953-4996-B2AE-34F063B81104Q41662619-30A42B9B-A6A8-4412-98CB-B0161F6920F6Q42265374-5D0792AD-81F9-475F-AE9F-94AFC5FBE04EQ47433633-40C35A61-75C2-4F82-9FC8-EA585636D149Q48072037-E2BA9F01-F99C-4278-BC1C-CBD0D56E3CB4Q48082613-D4998967-9D60-4C3E-8C4A-2141ECD377ABQ52611149-4D6DA520-D60E-424A-BA95-865322FF5807Q52653871-E2FF644A-F705-4A1A-9E05-C94ED3836240Q53049418-3570DE11-502D-4FE9-8A52-74F971175A15Q57176852-FB379864-E42B-4F37-85A8-36A5ECE8F02EQ58103509-AC4E9444-CD4F-49C5-B3E1-06DC5B1F4125Q61450673-192801DF-1781-4606-8C57-2BF029433336Q64115989-72EABBC3-DB0C-4007-82FC-A04D3648DE16Q90452254-E5BCE38E-9A2A-45F6-B30C-B3F85C4C60C3Q90699868-E992EADB-5C22-4642-8F2E-DA88397FEFF0Q91423105-665EF742-BA67-4AEE-93E2-29E5747A009CQ92396728-6A0335B3-46B4-451E-B2F8-F3B92D25CA63
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Scott P Kelly
@ast
Scott P Kelly
@en
Scott P Kelly
@es
Scott P Kelly
@sl
type
label
Scott P Kelly
@ast
Scott P Kelly
@en
Scott P Kelly
@es
Scott P Kelly
@sl
prefLabel
Scott P Kelly
@ast
Scott P Kelly
@en
Scott P Kelly
@es
Scott P Kelly
@sl
P1053
D-3195-2013
P106
P21
P2798
P31
P3829
P496
0000-0002-0375-1040